CHANGES IN THE PREVALENCE OF DRUG RESISTANT TUBERCULOSIS
https://doi.org/10.21292/2075-1230-2017-95-3-5-12
Abstract
The tendency of tuberculosis prevalence reduction observed in the Russian Federation is mostly related to the cases without multiple drug resistance (MDR). In general the number of MDR TB cases still tends to be increasing in the Russian Federation. Confident long-term reduction is registered only in the Central and North-Western Districts with relatively low level of MDR TB prevalence. From 2017 MDR TB patients are expected to prevail in the structure of the sputum positive cases which surely provides negative impact on the treatment efficiency and epidemic trends. The system of dispensary follow-up allows evaluating the annual number of MDT TB cases and following the ways of its increase and reduction. Taking MDR TB sources on and off the register is less intensive compared to the same flows of non-MDR infectious cases. The number of MDR TB sources is increasing mostly due new tuberculosis cases however acquired MDR TB makes significant contribution to the growth of MDR TB sources number. The increase in the ratio of respiratory MDR TB patients with sputum conversion to those died reflects the success in the improvement of the treatment strategy of MDR TB patients.
About the Authors
V. B. Galkin
St. Petersburg Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Candidate of Medical Sciences, Head of Tuberculosis Monitoring Laboratory,
2-4, Ligovsky Ave., St. Petersburg, 191036
S. A. Sterlikov
Central Research Institute for Public Health Organization and Informatization
Russian Federation
Russian Federation
Doctor of Medical Sciences,
11, Dobrolyubova St., Moscow, 127254
G. S. Balasanyants
St. Petersburg Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor,
2-4, Ligovsky Ave., St. Petersburg, 191036
P. K. Yablonsky
St. Petersburg Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Director,
2-4, Ligovsky Ave., St. Petersburg, 191036
References
1. Vasilyeva I.А., Borisov S.E., Son I.M.et al. Tuberkulez s mnozhestvennoy lekarstvennoy ustoychivostyu vozbuditelya. [Multiple drug resistant tuberculosis]. Tuberkulez v Rossiyskoy Federatsii 2012, 2013, 2014 g. Аnaliticheskiy obzor statisticheskikh pokazateley, ispolzuemykh v Rossiyskoy Federatsii i v mire. [Tuberculosis in the Russian Federation in 2011, 2013. 2014. Analytic review of statistic rates used in the Russian Federation and in the world]. Moscow, 2015, pp. 196-223.
2. Kazenny B.Ya., Kazenny А.B., Kirianova E.V. et al. Impact of effective treatment of new pulmonary tuberculosis patients and those with multiple drug resistance on the formation of the pool of tuberculous infection in Orel Region. Med. Alyans, 2013, no. 3. pp. 53-61. (In Russ.)
3. Decree no. 49 by the Russian Goskomstat as of 29.06.1999 On Approval of Annual Forms of the Federal State Statistic Surveillance Over Incidence in the Community, Vaccinations and Medical Care for Women and Children. (In Russ.)
4. Decree no. 80 by Rosstat as of 11.11.2005 On Approval of Statistic Tools for Statistic Surveillance by the Russian Ministry of Health and Social Development over Incidence of Certain Diseases in the Community. (In Russ.)
5. Decree no. 12 by Rosstat as of 28.01.2009 On Approval of Statistic Tools for Statistic Surveillance by the Russian Ministry of Health and Social Development in Healthcare. (In Russ.)
6. Decree no. 483 by Rosstat as of 31.12.2010 On Approval of Statistic Tools for Statistic Surveillance by the Russian Ministry of Health and Social Development over Activities of Healthcare Units. (In Russ.)
7. Sterlikov S.А., Malakhov V.N. Rezultaty vneshney otsenki kachestva laboratornoy diagnostiki tuberkuleza. [Results of external quality control of tuberculosis laboratory diagnostics]. http://www.mednet.ru/images/stories/files/CMT/FSVOK_2013.pdf
8. Global tuberculosis control: WHO report 2015, WHO/HTM/TB/2015.22, 192 p.
9. Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): protocol for a multicentric prospective observational study. A. Gupte, C. Padmapriyadarsini, V. Mave et al. DMJ Open, 2016, vol. 6, no. 2, 010542.
10. Pollett S., Banner P., O'Sullivan M.V., Ralph A.P. Epidemiology, Diagnosis and Management of Extra-Pulmonary Tuberculosis in a Low-Prevalence Country: A Four Year Retrospective Study in an Australian Tertiary Infectious Diseases Unit. PLoS One, 2016, March 10, DOI: 10.1371
Review
For citations:
Galkin V.B., Sterlikov S.A., Balasanyants G.S., Yablonsky P.K. CHANGES IN THE PREVALENCE OF DRUG RESISTANT TUBERCULOSIS. Tuberculosis and Lung Diseases. 2017;95(3):5-12. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-3-5-12
Views:
1883
Email this article 